Skip to content
MediaTech Blog UK

The Zimbabwean Government Turns Down ‘One-Sided’ US Healthcare Assistance Deal Because of Data Fears

Medical funding illustration
The offered American financial assistance was aimed at initiatives for HIV/Aids treatment and prevention, tuberculosis, and malaria.

Zimbabwe has turned down a substantial American health deal worth 367 million US dollars (£272m) over five years because of Washington's demand for sensitive data.

The decision came to light after a government memo from December was disclosed, revealing that President Emmerson Mnangagwa deemed the arrangement was "lopsided".

An official spokesperson has since clarified that the US was demanding access to health data for scientific study and profit but was not willing to share the resulting advantages from any future vaccines.

"We are forced to start the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the US had provided more than $1.9bn in health funding to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has urged more dialogue to find a agreement agreeable to both sides so the nation's vital HIV treatment initiative can proceed.

Wider Context

Zimbabwe's decision comes after a similar case in neighbouring Kenya, where a court suspended a similar health funding agreement following concerns were raised about the security of Kenyans' medical information.

Since resuming office recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.

USAID had administered aid for the American government, but Trump claimed its spending was "wasteful" and his administration was seeking direct bilateral agreements to enhance transparency and accountability.

As per statements, Sixteen nations in Africa have to date agreed to these new agreements, representing more than $18.3bn in committed funds.

Specifics of the Rejected Deal

This assistance for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".

"We are confident this collaboration could have provided significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently receiving HIV treatment via American-funded programmes," Tremont said.

However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".

"Zimbabwe was being asked to surrender its biological resources and data over an extended period, with no corresponding assurance of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.

"Put simply, our country would provide the raw materials for medical research without any certainty that the resulting innovations would be accessible to our people should a new disease outbreak emerge."

National Interest and International Frameworks

He also pointed out that the American exit from the global health body and its push of bilateral health agreements were undermining frameworks previously established through the global health agency.

The spokesperson cited its Pathogen Access and Benefit Sharing framework designed to manage potential global health emergencies.

"This framework is intended to ensure that when a nation provides its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the resources to develop them."

Zimbabwe's reservations regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.

"We are open to continued dialogue with our US partners on how subsequent co-operation could be structured in a way that honours the independence and dignity of each country."

Medical Community Reaction

A leading public health body expressed it acknowledged the official position, but suggested that negotiations need to persist considering much of the country's Aids initiatives depended on external financing.

"If specific concerns exist, including those relating to information security or implementation frameworks, these can often be resolved through detailed discussion and negotiated safeguards," it said.

This impasse underscores the ongoing debate between accepting vital foreign assistance and safeguarding local interests in an increasingly data-driven world.

Written by

Joshua West

A tech journalist and digital media strategist with over a decade of experience covering UK tech startups and media innovations.

MediaTech Blog UK

Type to search articles.